Record High Rally
The S&P 500 and Nasdaq are hitting unprecedented heights, creating an exciting investment opportunity. Our professional analysts have carefully selected the market-leading companies at the forefront of this powerful upward trend, giving you direct access to the growth engines behind this historic rally.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
About This Group of Stocks
Our Expert Thinking
This collection captures the momentum of the current market rally by focusing on the companies driving major indexes to all-time highs. These large-cap leaders in technology, AI, cloud computing, and semiconductors aren't just riding the wave—they're creating it, making them smart targets during this period of strong investor confidence.
What You Need to Know
These stocks represent influential market leaders whose performance significantly impacts major indexes. While they offer exposure to current bullish trends and cutting-edge industries, they may be more volatile than broader market investments. This group is ideal for growth-oriented investors looking to align with powerful market momentum.
Why These Stocks
Each company was specifically selected for its pivotal role in driving the current market rally. From AI innovators to cloud giants and semiconductor manufacturers, these businesses possess the market influence, strong fundamentals, and technological leadership that typically attract capital during bullish periods and fuel record-setting market performances.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+6.75%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 6.75% over the next year.
Stocks Rated Buy by Analysts
14 of 16 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 3.4% return last month.
Why You'll Want to Watch These Stocks
Record-Breaking Momentum
These companies aren't just participating in market gains—they're driving them. Their continued strength could signal further upside as investors flock to proven winners during bullish periods.
AI Revolution Leaders
Many stocks in this group are at the forefront of artificial intelligence, one of the most powerful technological shifts in decades. Their innovations are creating entirely new markets and revenue streams.
Market's Most Watched
Wall Street analysts and institutional investors are closely tracking these companies as barometers for the entire market's health. Their performance often signals broader economic trends before they become obvious.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.